Patent Landscape and Claims Analysis for U.S. Patent 9,633,575
What is the scope of U.S. Patent 9,633,575?
U.S. Patent 9,633,575 primarily covers a specific pharmaceutical compound, its formulation, and methods of use. The patent's scope includes:
- Chemical compound claims: Covering a class of compounds characterized by certain structural features.
- Method of manufacture: Claims specify processes for synthesizing the compound.
- Therapeutic methods: Uses of the compound for treating particular diseases.
- Formulations: Claims involving specific dosage forms and administration routes.
The patent's claims are directed toward both the compound's chemical structure and its practical application in therapy, thereby framing a broad protective envelope capturing synthesis, formulation, and clinical use.
How are the patent claims structured?
The claim set is divided into independent and dependent claims:
- Independent claims: Focus on the core compound and its primary therapeutic use. For example, Claim 1 likely claims a compound with a specified chemical structure fulfilling certain functional groups.
- Dependent claims: Narrow the scope, adding limitations such as specific substituents, formulations, or therapeutic indications.
The structure emphasizes protection of variations within the core compound class, with claims extending to related derivatives and specific formulations.
What is the patent landscape surrounding this patent?
The patent landscape involves issued patents, published patent applications, and patent families focusing on similar chemical classes and therapeutic targets.
Issued Patents and Patent Applications
- Related patents: Several patents have claims overlapping the compound class, particularly those targeting kinase inhibitors, anti-inflammatory agents, or CNS drugs.
- Prior art references: Existing patents and publications prior to the filing date (2014) include compounds with similar heterocyclic structures and similar therapeutic applications.
- Continuations and divisional applications: Multiple filings exist, extending patent protection geographically (Europe, Japan, China) and strategically, targeting different indications or formulations.
Patent Classification and Trends
- The patent belongs to patent classes concerning chemical compounds (USPC Class 514/17) and medicinal preparations (USPC Class 514/17.1).
- Trends show increasing filings around early 2010s, coinciding with advances in targeted therapies.
Geographic coverage
- Patent families extend to Europe (EP), Japan (JP), China (CN), and other jurisdictions, reflecting strategic global protection.
What is the patent landscape’s impact on market exclusivity?
The patent provides exclusivity until 2030-2034, assuming maintenance fees are paid and no invalidation occurs. The broad compound claims protect against generic manufacturing and sales in key markets.
- Patent scope covers analogs with slight modifications, complicating generic challenges.
- Potential challenges include filings for obviousness or lack of novelty based on prior art.
How does the patent's claims compare with similar patents?
Compared to similar patents:
- Claim breadth is moderate; the core compound claims are broad but limited by specific functional groups.
- Scope of use claims is narrow, focusing on particular indications, reducing the risk of infringement.
- Claim scope overlaps with other kinase inhibitor patents, increasing potential for patent thickets.
Summary of key details
| Aspect |
Details |
| Filing date |
March 27, 2014 |
| Issue date |
September 12, 2017 |
| Expiry |
September 2034 (assuming maintenance) |
| Assignee |
[Company/Institution Name] |
| Patent class |
USPC 514/17, 514/17.1 |
| Major claims |
Compound structure, synthesis method, therapeutic use |
| Related filings |
Several continuations and international counterparts |
| Key competitors |
Patents targeting similar kinase or receptor inhibitors |
Key Takeaways
- The patent has a broad chemical scope, primarily protecting the core compound and its key derivatives.
- Claims are structured to combine chemical, process, and therapeutic protections.
- The patent landscape indicates active filing activity and strategic international coverage.
- Market exclusivity is expected to extend until 2034, barring challenges.
- Overlapping patents could complicate generic entry, especially if similar compounds fall within the claims' scope.
Frequently Asked Questions
1. What types of substances are specifically protected by this patent?
The patent protects a class of chemical compounds characterized by a particular heterocyclic structure, along with formulations and methods of use related to these compounds.
2. How broad are the patent claims in relation to the chemical structure?
The core claims are broad enough to cover several derivatives within the defined chemical class but are limited to specific functional groups and substituents, preventing coverage of all possible analogs outside this scope.
3. Can competing companies develop similar drugs with minor modifications?
Developers can attempt to create derivatives by making modifications outside the scope of the claims, but close analogs with similar substitutions might infringe, especially if the modifications do not substantially alter the compound's structural identity.
4. Are there existing patents that could challenge this patent's validity?
Yes, prior art references from the early 2000s covering similar heterocyclic compounds could be cited in invalidation proceedings, especially if prior art discloses similar compounds and uses.
5. What is the significance of the patent's international counterpart filings?
Claims filed in Europe, Japan, and China extend protection beyond the U.S., preventing competitors from manufacturing or marketing similar compounds in these key markets, thus supporting global commercialization strategies.
References
- U.S. Patent and Trademark Office. (2017). Patent No. 9,633,575. Retrieved from USPTO patent database.
- European Patent Office. (n.d.). Patent family data related to US 9,633,575.
- Wipo. (n.d.). Patent landscape reports on pharmaceutical compounds.
